378 results on '"Petrie, Joshua G."'
Search Results
2. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses
3. Epidemiology of Respiratory Syncytial Virus in Adults and Children With Medically Attended Acute Respiratory Illness Over Three Seasons.
4. Comparing the Etiology of Viral Acute Respiratory Illnesses Between Children Who Do and Do Not Attend Childcare
5. Epidemiology of RSV in Adults and Children with Medically-Attended Acute Respiratory Illness over Three Seasons
6. Health Care–Acquired Viral Respiratory Diseases
7. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
8. A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa.
9. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection
10. Incidence and outcomes of hospital-associated respiratory virus infections by viral species
11. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals
12. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness-- Wisconsin, October 2022-February 2023
13. The Household Influenza Vaccine Effectiveness Study : Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine
14. Prior-Season Vaccination and Risk of Influenza During the 2014–2015 Season in the United States
15. The Doctrine of Original Antigenic Sin: Separating Good From Evil
16. Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness
17. Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015
18. Incidence and outcomes of hospital-associated respiratory virus infections by viral species
19. Respiratory syncytial virus hospitalization in middle-aged and older adults
20. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
21. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
22. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
23. Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014–2015
24. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season
25. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States
26. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013–2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated
27. Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013
28. K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection
29. Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
30. Respiratory virus circulation during the first year of the COVID‐19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort
31. Investigating Epidemiologic and Molecular Links Between Patients With Community- and Hospital-Acquired Influenza A: 2017–2018 and 2019–2020, Michigan
32. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination
33. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
34. Use of Influenza Antiviral Medications Among Outpatients at High Risk for Influenza-Associated Complications During the 2013–2014 Influenza Season
35. Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
36. Influenza Vaccine Effectiveness in Households With Children During the 2012-2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility
37. Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
38. Respiratory Virus Circulation during the First Year of the COVID-19 Pandemic in the Household Influenza Vaccine Evaluation (HIVE) Cohort
39. Epidemiology of RSV-A and RSV-B in Adults and Children with Medically-Attended Acute Respiratory Illness over Three Seasons
40. Factors associated with influenza vaccine receipt in community dwelling adults and their children
41. Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons
42. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates
43. The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
44. Influenza Vaccine Effectiveness in the Community and the Household
45. Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort
46. Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains
47. The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade
48. Effectiveness of COVID-19 mRNA vaccine booster dose relative to primary series during a period of Omicron circulation
49. Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
50. Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.